Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma
- Thomas Powles
- , Robert J. Motzer
- , Bernard Escudier
- , Sumanta Pal
- , Christian Kollmannsberger
- , Joanna Pikiel
- , Howard Gurney
- , Sun Young Rha
- , Se Hoon Park
- , Poul F. Geertsen
- , Marine Gross-Goupil
- , Enrique Grande
- , Cristina Suarez
- , David W. Markby
- , Alan Arroyo
- , Mark Dean
- , Toni K. Choueiri
- , Daniel George
- Queen Mary University of London
- Memorial Sloan-Kettering Cancer Center
- Gustave Roussy
- City of Hope National Med Center
- Provincial Health Services Authority
- Wojewodzkie Centrum Onkologii
- Macquarie University
- Yonsei University
- University of Copenhagen
- Hôpital Saint-André
- Hospital Ramon y Cajal
- Vall d’Hebron University Hospital
- Exelixis Inc.
- Dana-Farber Cancer Institute
- Duke University
Research output: Contribution to journal › Article › peer-review
80
Link opens in a new tab
Scopus
citations